SUBSCRIPTION AGREEMENTSubscription Agreement • April 19th, 2017 • Edge Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This subscription agreement (this “Subscription Agreement”) is made as of April 19, 2017, by and among the Investors identified on the signature pages hereto (each an “Investor” and together “Investors”), and Edge Therapeutics, Inc., a Delaware corporation (the “Company”), and the parties hereto agree as follows:
